1932
0
  1. Home
  2. A-Z Publications
  3. Annual Review of Virology
  4. Volume 3, 2016
  5. Article

Annual Review of Virology

Volume 3, 2016

Epstein-Barr Virus: The Path from Latent to Productive Infection

Abstract

The intrinsic properties of different viruses have driven their study. For example, the capacity for efficient productive infection of cultured cells by herpes simplex virus 1 has made it a paradigm for this mode of infection for herpesviruses in general. Epstein-Barr virus, another herpesvirus, has two properties that have driven its study: It causes human cancers, and it exhibits a tractable transition from its latent to its productive cycle in cell culture. Here, we review our understanding of the path Epstein-Barr virus follows to move from a latent infection to and through its productive cycle. We use information from human infections to provide a framework for describing studies in cell culture and, where possible, the molecular resolutions from these studies. We also pose questions whose answers we think are pivotal to understanding this path, and we provide answers where we can.

Keyword(s): Epstein-Barr virus, latent phase, lytic phase, transcriptional regulation
Loading

Article metrics loading...

/content/journals/10.1146/annurev-virology-110615-042358
2016-09-29
2024-04-16
Loading full text...

Full text loading...

/deliver/fulltext/virology/3/1/annurev-virology-110615-042358.html?itemId=/content/journals/10.1146/annurev-virology-110615-042358&mimeType=html&fmt=ahah

Literature Cited

  1. Sugden B. 1.  2014. Epstein-Barr virus: the path from association to causality for a ubiquitous human pathogen. PLOS Biol 12:e1001939 [Google Scholar]
  2. Babcock GJ, Decker LL, Volk M, Thorley-Lawson DA. 2.  1998. EBV persistence in memory B cells in vivo. Immunity 9:395–404 [Google Scholar]
  3. Greenspan JS, Greenspan D, Lennette ET, Abrams DI, Conant MA. 3.  et al. 1985. Replication of Epstein-Barr virus within the epithelial cells of oral hairy leukoplakia, an AIDS-associated lesion. N. Engl. J. Med. 313:1564–71 [Google Scholar]
  4. Epstein JB, Fatahzadeh M, Matisic J, Anderson G. 4.  1995. Exfoliative cytology and electron microscopy in the diagnosis of hairy leukoplakia. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 79:564–69 [Google Scholar]
  5. Fernandez JF, Benito MA, Lizaldez EB, Montanes MA. 5.  1990. Oral hairy leukoplakia: a histopathologic study of 32 cases. Am. J. Dermatopathol. 12:571–78 [Google Scholar]
  6. Bedell MA, Hudson JB, Golub TR, Turyk ME, Hosken M. 6.  et al. 1991. Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation. J. Virol. 65:2254–60 [Google Scholar]
  7. Becker J, Leser U, Marschall M, Langford A, Jilg W. 7.  et al. 1991. Expression of proteins encoded by Epstein-Barr virus trans-activator genes depends on the differentiation of epithelial cells in oral hairy leukoplakia. PNAS 88:8332–36 [Google Scholar]
  8. Berean K, Epstein JB. 8.  1996. Correspondence re: Brandwein M, Nuovo G, Ramer M, Orlowski W, Miller L: Epstein-Barr virus reactivation in hairy leukoplakia. Mod Pathol 9:298, 1996. Mod. Pathol. 9:869–70 [Google Scholar]
  9. Lee DY, Sugden B. 9.  2008. The LMP1 oncogene of EBV activates PERK and the unfolded protein response to drive its own synthesis. Blood 111:2280–89 [Google Scholar]
  10. Sugden B. 10.  1984. Expression of virus-associated functions in cells transformed in vitro by Epstein-Barr virus: Epstein-Barr virus cell surface antigen and virus-release from transformed cells. Immune Deficiency and Cancer: Epstein-Barr Virus and Lymphoproliferative Malignancies TD Purtilo 165–77 New York: Springer [Google Scholar]
  11. Tsao SW, Tsang CM, Pang PS, Zhang G, Chen H, Lo KW. 11.  2012. The biology of EBV infection in human epithelial cells. Semin. Cancer Biol. 22:137–43 [Google Scholar]
  12. Shannon-Lowe CD, Neuhierl B, Baldwin G, Rickinson AB, Delecluse HJ. 12.  2006. Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. PNAS 103:7065–70 [Google Scholar]
  13. Shannon-Lowe C, Adland E, Bell AI, Delecluse HJ, Rickinson AB, Rowe M. 13.  2009. Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification. J. Virol. 83:7749–60 [Google Scholar]
  14. Temple RM, Zhu J, Budgeon L, Christensen ND, Meyers C, Sample CE. 14.  2014. Efficient replication of Epstein-Barr virus in stratified epithelium in vitro. PNAS 111:16544–49 [Google Scholar]
  15. Shimizu N, Tanabe-Tochikura A, Kuroiwa Y, Takada K. 15.  1994. Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: Malignant phenotypes of BL cells are dependent on EBV. J. Virol. 68:6069–73 [Google Scholar]
  16. Imai S, Nishikawa J, Takada K. 16.  1998. Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J. Virol. 72:4371–78 [Google Scholar]
  17. Glaser R, Zhang HY, Yao KT, Zhu HC, Wang FX. 17.  et al. 1989. Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. PNAS 86:9524–28 [Google Scholar]
  18. Strong MJ, Baddoo M, Nanbo A, Xu M, Puetter A, Lin Z. 18.  2014. Comprehensive high-throughput RNA sequencing analysis reveals contamination of multiple nasopharyngeal carcinoma cell lines with HeLa cell genomes. J. Virol. 88:10696–704 [Google Scholar]
  19. Hammerschmidt W, Sugden B. 19.  2013. Replication of Epstein-Barr viral DNA. Cold Spring Harb. Perspect. Biol. 5:a013029 [Google Scholar]
  20. Tempera I, Lieberman PM. 20.  2014. Epigenetic regulation of EBV persistence and oncogenesis. Semin. Cancer Biol. 26:22–29 [Google Scholar]
  21. Kang MS, Kieff E. 21.  2015. Epstein-Barr virus latent genes. Exp. Mol. Med. 47:e131 [Google Scholar]
  22. Price AM, Luftig MA. 22.  2014. Dynamic Epstein-Barr virus gene expression on the path to B-cell transformation. Adv. Virus Res. 88:279–313 [Google Scholar]
  23. Vereide DT, Sugden B. 23.  2011. Lymphomas differ in their dependence on Epstein-Barr virus. Blood 117:1977–85 [Google Scholar]
  24. Miller G, El-Guindy A, Countryman J, Ye J, Gradoville L. 24.  2007. Lytic cycle switches of oncogenic human gammaherpesviruses. Adv. Cancer Res. 97:81–109 [Google Scholar]
  25. Murata T, Tsurumi T. 25.  2014. Switching of EBV cycles between latent and lytic states. Rev. Med. Virol. 24:142–53 [Google Scholar]
  26. Kenney SC, Mertz JE. 26.  2014. Regulation of the latent-lytic switch in Epstein-Barr virus. Semin. Cancer Biol. 26:60–68 [Google Scholar]
  27. Feederle R, Kost M, Baumann M, Janz A, Drouet E. 27.  et al. 2000. The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J 19:3080–89 [Google Scholar]
  28. Adamson AL, Darr D, Holley-Guthrie E, Johnson RA, Mauser A. 28.  et al. 2000. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases. J. Virol. 74:1224–33 [Google Scholar]
  29. Chang LK, Chuang JY, Nakao M, Liu ST. 29.  2010. MCAF1 and synergistic activation of the transcription of Epstein-Barr virus lytic genes by Rta and Zta. Nucleic Acids Res 38:4687–700 [Google Scholar]
  30. Bhende PM, Seaman WT, Delecluse HJ, Kenney SC. 30.  2004. The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome. Nat. Genet. 36:1099–104 [Google Scholar]
  31. Bergbauer M, Kalla M, Schmeinck A, Gobel C, Rothbauer U. 31.  et al. 2010. CpG-methylation regulates a class of Epstein-Barr virus promoters. PLOS Pathog 6:e1001114 [Google Scholar]
  32. Kintner C, Sugden B. 32.  1981. Conservation and progressive methylation of Epstein-Barr viral DNA sequences in transformed cells. J. Virol. 38:305–16 [Google Scholar]
  33. Wille CK, Nawandar DM, Panfil AR, Ko MM, Hagemeier SR, Kenney SC. 33.  2013. Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication. J. Virol. 87:935–50 [Google Scholar]
  34. Hammerschmidt W, Sugden B. 34.  1988. Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell 55:427–33 [Google Scholar]
  35. Schepers A, Pich D, Hammerschmidt W. 35.  1993. A transcription factor with homology to the AP-1 family links RNA transcription and DNA replication in the lytic cycle of Epstein-Barr virus. EMBO J 12:3921–29 [Google Scholar]
  36. Fixman ED, Hayward GS, Hayward SD. 36.  1992. trans-Acting requirements for replication of Epstein-Barr virus ori-Lyt. J. Virol. 66:5030–39 [Google Scholar]
  37. Baumann M, Feederle R, Kremmer E, Hammerschmidt W. 37.  1999. Cellular transcription factors recruit viral replication proteins to activate the Epstein-Barr virus origin of lytic DNA replication, oriLyt. EMBO J 18:6095–105 [Google Scholar]
  38. Pfuller R, Hammerschmidt W. 38.  1996. Plasmid-like replicative intermediates of the Epstein-Barr virus lytic origin of DNA replication. J. Virol. 70:3423–31 [Google Scholar]
  39. Falkenberg M, Lehman IR, Elias P. 39.  2000. Leading and lagging strand DNA synthesis in vitro by a reconstituted herpes simplex virus type 1 replisome. PNAS 97:3896–900 [Google Scholar]
  40. Zimmermann J, Hammerschmidt W. 40.  1995. Structure and role of the terminal repeats of Epstein-Barr virus in processing and packaging of virion DNA. J. Virol. 69:3147–55 [Google Scholar]
  41. Zhou H, Schmidt SC, Jiang S, Willox B, Bernhardt K. 41.  et al. 2015. Epstein-Barr virus oncoprotein super-enhancers control B cell growth. Cell Host Microbe 17:205–16 [Google Scholar]
  42. O'Grady T, Cao S, Strong MJ, Concha M, Wang X. 42.  et al. 2014. Global bidirectional transcription of the Epstein-Barr virus genome during reactivation. J. Virol. 88:1604–16 [Google Scholar]
  43. Wyrwicz LS, Rychlewski L. 43.  2007. Identification of herpes TATT-binding protein. Antivir. Res. 75:167–72 [Google Scholar]
  44. Gruffat H, Kadjouf F, Mariame B, Manet E. 44.  2012. The Epstein-Barr virus BcRF1 gene product is a TBP-like protein with an essential role in late gene expression. J. Virol. 86:6023–32 [Google Scholar]
  45. Djavadian R, Chiu YF, Johannsen E. 45.  2016. An Epstein-Barr virus-encoded protein complex requires an origin of lytic replication in cis to mediate late gene transcription. PLOS Pathog. 12:e1005718 [Google Scholar]
  46. Aubry V, Mure F, Mariame B, Deschamps T, Wyrwicz LS. 46.  et al. 2014. Epstein-Barr virus late gene transcription depends on the assembly of a virus-specific preinitiation complex. J. Virol. 88:12825–38 [Google Scholar]
  47. Mocarski ES Jr. 47.  2007. Comparative analysis of herpesvirus-common proteins. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis A Arvin, G Campadelli-Fiume, E Mocarski, PS Moore et al. Cambridge, UK: Cambridge Univ. Press [Google Scholar]
  48. Wang WH, Chang LK, Liu ST. 48.  2011. Molecular interactions of Epstein-Barr virus capsid proteins. J. Virol. 85:1615–24 [Google Scholar]
  49. Henson BW, Perkins EM, Cothran JE, Desai P. 49.  2009. Self-assembly of Epstein-Barr virus capsids. J. Virol. 83:3877–90 [Google Scholar]
  50. Bloss TA, Sugden B. 50.  1994. Optimal lengths for DNAs encapsidated by Epstein-Barr virus. J. Virol. 68:8217–22 [Google Scholar]
  51. Farina A, Feederle R, Raffa S, Gonnella R, Santarelli R. 51.  et al. 2005. BFRF1 of Epstein-Barr virus is essential for efficient primary viral envelopment and egress. J. Virol. 79:3703–12 [Google Scholar]
  52. Granato M, Feederle R, Farina A, Gonnella R, Santarelli R. 52.  et al. 2008. Deletion of Epstein-Barr virus BFLF2 leads to impaired viral DNA packaging and primary egress as well as to the production of defective viral particles. J. Virol. 82:4042–51 [Google Scholar]
  53. Lee CP, Liu PT, Kung HN, Su MT, Chua HH. 53.  et al. 2012. The ESCRT machinery is recruited by the viral BFRF1 protein to the nucleus-associated membrane for the maturation of Epstein-Barr virus. PLOS Pathog 8:e1002904 [Google Scholar]
  54. Johnson DC, Baines JD. 54.  2011. Herpesviruses remodel host membranes for virus egress. Nat. Rev. Microbiol. 9:382–94 [Google Scholar]
  55. Wang X, Kenyon WJ, Li Q, Mullberg J, Hutt-Fletcher LM. 55.  1998. Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells. J. Virol. 72:5552–58 [Google Scholar]
  56. Li Q, Spriggs MK, Kovats S, Turk SM, Comeau MR. 56.  et al. 1997. Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. J. Virol. 71:4657–62 [Google Scholar]
  57. Haan KM, Kwok WW, Longnecker R, Speck P. 57.  2000. Epstein-Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor. J. Virol. 74:2451–54 [Google Scholar]
  58. Borza CM, Morgan AJ, Turk SM, Hutt-Fletcher LM. 58.  2004. Use of gHgL for attachment of Epstein-Barr virus to epithelial cells compromises infection. J. Virol. 78:5007–14 [Google Scholar]
  59. Borza CM, Hutt-Fletcher LM. 59.  2002. Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat. Med. 8:594–99 [Google Scholar]
  60. Chiu YF, Sugden AU, Sugden B. 60.  2013. Epstein-Barr viral productive amplification reprograms nuclear architecture, DNA replication, and histone deposition. Cell Host Microbe 14:607–18 [Google Scholar]
  61. Sugimoto A, Sato Y, Kanda T, Murata T, Narita Y. 61.  et al. 2013. Different distributions of Epstein-Barr virus early and late gene transcripts within viral replication compartments. J. Virol. 87:6693–99 [Google Scholar]
  62. Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ. 62.  et al. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207–11 [Google Scholar]
  63. Kintner CR, Sugden B. 63.  1979. The structure of the termini of the DNA of Epstein-Barr virus. Cell 17:661–71 [Google Scholar]
  64. Hammerschmidt W, Sugden B. 64.  1989. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 340:393–97 [Google Scholar]
  65. Wen W, Iwakiri D, Yamamoto K, Maruo S, Kanda T, Takada K. 65.  2007. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes. J. Virol. 81:1037–42 [Google Scholar]
/content/journals/10.1146/annurev-virology-110615-042358
Loading
Epstein-Barr Virus: The Path from Latent to Productive Infection
Annual Review of Virology 3, 359 (2016); https://doi.org/10.1146/annurev-virology-110615-042358
/content/journals/10.1146/annurev-virology-110615-042358
/content/journals/10.1146/annurev-virology-110615-042358
Loading

Data & Media loading...

  • Article Type: Review Article

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error